Cap 1 Messenger RNA Synthesis with Co‐transcriptional CleanCap ® Analog by In Vitro Transcription

Henderson, Jordana M., Ujita, Andrew, Hill, Elizabeth, Yousif‐Rosales, Sally, Smith, Cory, Ko, Nicholas, McReynolds, Taylor, Cabral, Charles R. +2 more·2021·Current Protocols
DOI 10.1002/cpz1.39

Cited by (231)

Items 101–200 of 231

  1. Urea supplementation improves mRNA in vitro transcription by decreasing both shorter and longer RNA byproducts
    Francis Combes, Frida J Pettersson, Bui Thanh-Huong, Alicja Molska, Artem Komissarov, Jérémie Parot, Sven Even Borgos · 2024 · RNA Biology
  2. Comprehensive chromatographic assessment of forced degraded in vitro transcribed mRNA
    Daniel M. Dayeh, Jaclyn Cika, Youmi Moon, Steven Henderson, Deanna Di Grandi, Yue Fu, Kathir Muthusamy, Nisha T. Palackal, Peter M. Ihnat, Erica A. Pyles · 2024 · Journal of Chromatography A
  3. In vivo demonstration of enhanced mRNA delivery by cyclic disulfide-containing lipid nanoparticles for facilitating endosomal escape
    Seigo Kimura, Kana Okada, Noriaki Matsubara, Fangjie Lyu, Susumu Tsutsumi, Yasuaki Kimura, Fumitaka Hashiya, Masahito Inagaki, Naoko Abe, Hiroshi Abe · 2025 · RSC Medicinal Chemistry
  4. Omicron‐specific mRNA vaccine induced cross‐protective immunity against ancestral SARS‐CoV‐2 infection with low neutralizing antibodies
    Kuan‐Yin Shen, Chung‐Hsiang Yang, Chiung‐Tong Chen, Hui‐Min Ho, Fang‐Feng Chiu, Chiung‐Yi Huang, Hung‐Chun Liao, Chia‐Wei Hsu, Guann‐Yi Yu, Ching‐Len Liao et al. · 2022 · Journal of Medical Virology
  5. Coding Therapeutic Nucleic Acids from Recombinant Proteins to Next-Generation Vaccines: Current Uses, Limitations, and Future Horizons
    Gamaleldin I. Harisa, Tarek M. Faris, Abdelrahman Y. Sherif, Riyad F. Alzhrani, Saleh A. Alanazi, Neveen A. Kohaf, Fars Kaed Alanazi · 2023 · Molecular Biotechnology
  6. Effective Synthesis of High-Integrity mRNA Using In Vitro Transcription
    Wei He, Xinya Zhang, Yangxiaoyu Zou, Ji Li, Chong Wang, Yu-Cai He, Qiuheng Jin, Jianren Ye · 2024 · Molecules
  7. The mRNA-Based Innovative Strategy: Progress and Challenges
    Huayuan Zhou, Dali Wei, Zhejie Chen, Hao Chen, Chuhuang Dong, Weiyao Cai, Jiawen Wang, Xueliang Liu, Yuqing Li, Yu Yang et al. · 2026 · Nano-Micro Letters
  8. Nanopore direct RNA sequencing and the epitranscriptome: Advances in mapping native RNA landscapes
    Tianyuan Zhang, Jia Li, Chao Tang, You Wu, H Wu, Zhu Xi-Tong, Ziyang Luo, Hang Qin, Lishan Ding, Yu Zeng et al. · 2026 · iMeta
  9. Cell Reprogramming and Differentiation Utilizing Messenger RNA for Regenerative Medicine
    Masahito Inagaki · 2023 · Journal of Developmental Biology
  10. Quality by Digital Design for Developing Platform RNA Vaccine and Therapeutic Manufacturing Processes
    Adithya Nair, Kate A. Loveday, Charlotte Kenyon, Jixin Qu, Zoltán Kis · 2024 · Methods in molecular biology
  11. Developing Vaccines in Pancreatic Adenocarcinoma: Trials and Tribulations
    Thuy Xuan Phan, Darrell Fan, Laleh Golkar Melstrom · 2024 · Current Oncology
  12. Flow-NMR as a Process-Monitoring Tool for mRNA IVT Reaction
    Aritra Sarkar, Guogang Dong, Jennifer Quaglia-Motta, Kelly Sackett · 2023 · Journal of Pharmaceutical Sciences
  13. BioNTech/Pfizer (BNT162b2) COVID-19 mRNA vaccine: manufacturing, immunogenicity, efficacy and safety
    Esraa Alkhalil, Bashar Jarad, Tala Al Saleh, Wafaa Aldarwish, Dima Joujeh · 2025 · Prospects in Pharmaceutical Sciences
  14. Therapeutic Application of mRNA for Genetic Diseases
    Paul J. L. Schürmann, Stijn v. Breda Vriesman, Jose Castro-Alpízar, Sander A. A. Kooijmans, Edward E. S. Nieuwenhuis, Raymond Michel Schiffelers, Sabine A. Fuchs · 2025 · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology
  15. Towards mRNA therapeutics 2.0
    Kenneth R. Chien, Kylie S. Foo, Nevin Witman · 2026 · Nature Reviews Drug Discovery
  16. Mobile On Demand COVID-19 Vaccine Production Units for Developing Countries
    Steffen R. Fahr, Samantha Ayde Peña‐Benavides, Lukas Thiel, Carl Sengoba, Kaan Karacasulu, Nina Ihling, Juan Eduardo Sosa‐Hernández, Gary L. Gilleskie, John M. Woodley, Roberto Parra‐Saldívar et al. · 2022 · Industrial & Engineering Chemistry Research
  17. Reverse vaccinology-based design of multivalent multiepitope mRNA vaccines targeting key viral proteins of Herpes Simplex Virus type-2
    N S Suneesh, Kishore Dhotre, Pratik Mahajan, Debashree Dass, Anwesha Banerjee, Nikhat Jamal Siddiqi, Abdul Malik, Manali Joshi, Abdul Arif Khan, Vijay Nema et al. · 2025 · Frontiers in Immunology
  18. An immunoinformatics approach in designing high-coverage mRNA multi-epitope vaccine against multivariant SARS-CoV-2
    Ernawati Arifin Giri-Rachman, Al Mirahma Febri Kurnianti, Rizarullah Rizarullah, Aditya Hanung Setyadi, Anita Artarini, Marselina Irasonia Tan, Catur Riani, Dessy Natalia, Reza Aditama, Husna Nugrahapraja · 2025 · Journal of Genetic Engineering and Biotechnology
  19. Mesenchymal stem cell engineering by ARCA analog-capped mRNA
    Anna Andrzejewska, Renata Grzela, Anna Stankiewicz-Drogoń, Piotr Rogujski, Siranjeevi Nagaraj, Edward Darżynkiewicz, Barbara Łukomska, Mirosław Janowski · 2023 · Molecular Therapy — Nucleic Acids
  20. Future Perspectives for the Identification and Sequencing of Nicotinamide Adenine Dinucleotide-Capped RNAs
    Marvin Möhler, Andres Jäschke · 2023 · Accounts of Chemical Research
  21. Recombinant T7 RNA polymerase production using ClearColi BL21(DE3) and animal-free media for in vitro transcription
    Qianying Liang, Bowen Tu, Lun Cui · 2024 · Applied Microbiology and Biotechnology
  22. On‐column capping of poly dT media‐tethered mRNA accomplishes high capping efficiency, enhanced mRNA recovery, and improved stability against RNase
    Shiyi Che, Feng Xue, Zhengjun Li, Zhiguo G. Su, Guanghui Ma, Zhikao Li, Aibing Yu, Minsu Liu, Songping Zhang · 2023 · Biotechnology and Bioengineering
  23. Physicochemical and functional assessment of messenger RNA 5′Cap-end impurities under forced degradation conditions
    J. Hutchinson, Fritz Schweikart, R. Shannon, Aditya Murthy, Stephanie M. Bates, S. Leone, Tracy A Nissan, D. Sideris, C. Lal, J. Button et al. · 2025 · Molecular Therapy — Nucleic Acids
  24. The role of excipients in lipid nanoparticle metabolism: implications for enhanced therapeutic effect
    Karlene L. M. Knaggs, Yikai Sun, Brianna A. Walz, Janice Pang, Omar F. Khan · 2025 · Therapeutic Delivery
  25. A modular vaccine platform for optimized lipid nanoparticle mRNA immunogenicity
    Zhenhao Fang, Valter Silva Monteiro, Changin Oh, Kawthar Al Janabi, Luciano Romero, Nabihah Ahsan, Luojia Yang, Lei Peng, Daniel DiMaio, Carolina Gonçalves de Oliveira Lucas et al. · 2025 · Nature Biomedical Engineering
  26. Enhancing cap-independent translation of linear mRNA
    Sebastian Golojuch, Brendan Largey, Afaf Helmy El-Sagheer, Tom P Brown · 2025 · Nature Communications
  27. mRNA Manufacturing and Single‐use Technology – A Perfect Liaison
    António Lima Grilo, Diego R. Schmidhalter · 2022 · Chemie Ingenieur Technik
  28. Nonreplicating synthetic mRNA vaccines: A journey through the European (Journal of Immunology) history
    Steve Pascolo · 2023 · European Journal of Immunology
  29. mRNA-Based Nanomedicine: A New Strategy for Treating Infectious Diseases and Beyond
    Satyendra Prakash · 2023 · European Journal of Drug Metabolism and Pharmacokinetics
  30. PCR-generated DNA templates enable efficient, rapid, and cost-effective mRNA synthesis
    Naveen Kumar, Nicholas C. Hazell, Jiani Bei, Tina K. Nguyen, Haitao Hu · 2025 · Methods
  31. High-efficiency editing in hematopoietic stem cells and the HUDEP-2 cell line based on in vitro mRNA synthesis
    Nikoletta Y. Papaioannou, Petros Patsali, Basma Naiisseh, Panayiota L. Papasavva, Lola Koniali, Ryo Kurita, Yukio Nakamura, Soteroula Christou, Maria Sitarou, Claudio Mussolino et al. · 2023 · Frontiers in Genome Editing
  32. Sequence simplification of antigen coding IVT mRNA allows accelerated synthetic DNA template generation and epitope immunogenicity validation
    Arthur Esprit, Dorien Autaers, Ilke Aernout, Ine Lentacker, Steve Pascolo, Kris Thielemans, Karine Breckpot, Lorenzo Franceschini · 2025 · Molecular Therapy — Nucleic Acids
  33. Towards T7 RNA polymerase (T7RNAP)-based expression system in yeast: challenges and opportunities
    David Sáez Moreno, Udi Qimron, Joana Azeredo, Lucı́lia Domingues · 2022 · Bioengineered
  34. Transitional Insight into the RNA-Based Oligonucleotides in Cancer Treatment
    Hamed Tabasi, Samaneh Mollazadeh, Elham Fazeli, Khalil Abnus, Seyed Mohammad Taghdisi, Mohammad Ramezani, Mona Alibolandi · 2023 · Applied Biochemistry and Biotechnology
  35. Future prospects in mRNA vaccine development
    Londiwe Simphiwe Mbatha, Jude Akinyelu, Fiona Maiyo, Tukayi Kudanga · 2023 · Biomedical Materials
  36. A (RP)UHPLC/UV analytical method to quantify dsRNA during the mRNA vaccine manufacturing process
    Sara Sousa Rosa, Shuran Zhang, Yustika Sari, Marco P. C. Marques · 2024 · Analytical Methods
  37. Quantitative Profiling of Human Translation Initiation Reveals Regulatory Elements that Potently Affect Endogenous and Therapeutically Modified mRNAs
    Cole J.T. Lewis, Li Xie, Shivani Bhandarkar, Danni Jin, Kyrillos Abdallah, Austin S. Draycott, Yixuan Chen, Carson C. Thoreen, Wendy V. Gilbert · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  38. Engineering Anti-Tumor Immunity: An Immunological Framework for mRNA Cancer Vaccines
    Olivia Roy, Karen S. Anderson · 2025 · Vaccines
  39. Navigating molecular therapies: The emerging role of mRNA in treating inherited metabolic diseases
    Jose Castro-Alpízar, M.J. Lenderink, Edward E. S. Nieuwenhuis, Sander A. A. Kooijmans, Sabine A. Fuchs · 2025 · Molecular Genetics and Metabolism
  40. In vivo CAR-T therapy: from molecular design to precision delivery
    Huixian Li, Wenjing Wen, Xuan Zhao, Gaofeng Liang · 2026 · Journal of Nanobiotechnology
  41. Quality Control of mRNA Vaccines by Synthetic Ribonucleases: Analysis of the Poly‐A‐Tail
    Felix Zellmann, Nina Schmauk, Nina S. Murmann, Madeleine Böhm, Alexander Schwenger, Michael Göbel · 2024 · ChemBioChem
  42. The Recent Research Progress of the Tumor mRNA Vaccine
    Hao Zhao, Miying Li, Jiaren Zhou, Lidan Hu, Shaohong Lu, Pan Li · 2024 · Vaccines
  43. Synthesis of hydrophobic-tagged 2′-deoxy-modified cap analogs and its effect on mRNA translation
    Zheyu Meng, Yuko Nakashima, Masahito Inagaki, Zhenmin Li, Susit Acharyya, Fumitaka Hashiya, Naoko Abe, Yasuaki Kimura, Hiroshi Abe · 2025 · Bulletin of the Chemical Society of Japan
  44. Established Protocols for cRNA Expression and Voltage-Clamp Characterization of the P2X7 Receptor in Xenopus laevis Oocytes
    Günther Schmalzing, F Markwárdt · 2022 · Methods in molecular biology
  45. Detection of residual T7 RNA polymerase used in mRNA in vitro transcription by Simple Western
    Yvonne Shieh, Andrew R. Swartz, Richard R. Rustandi · 2024 · Electrophoresis
  46. The P(III)‐Amidite Based Synthesis of Stable Isotope Labeled mRNA‐Cap‐Structures Enables their Sensitive Quantitation from Brain Tissue
    Alexander Ripp, Martina Krämer, Vanessa Barth, Patrick Moser, Thomas Haas, Jyoti Singh, Tamara Huck, Lukas Gleue, Kristina Friedland, Mark Helm et al. · 2024 · Angewandte Chemie International Edition
  47. Design and Expression of Fasciola hepatica Multiepitope Constructs Using mRNA Vaccine Technology
    Javier Sánchez‐Montejo, Tania Strilets, Raúl Manzano-Román, Julio López‐Abán, Mariano A. García-Blanco, Belén Vicente, Antonio Muro · 2025 · International Journal of Molecular Sciences
  48. Synthesis of Nucleic Acids
    Jonathan K. Watts, Michael John Gait · 2022 · Royal Society of Chemistry eBooks
  49. Novel trinucleotide mRNA capping reagents: improved synthetic route and efficient cotranscriptional incorporation in mRNA
    Chunping Xu, Russell Cousins, Ilya Ilichev, Jesús Alejandro Orozco Ceja, Paul T. Ludford, Vagarshak Begoyan, Marc Turner, Maria Cristina Leme Godoy dos Santos, Coleen Vo, Farinaz Rezvani et al. · 2025 · RNA
  50. Single-step recovery of mRNA via multimodal chromatography to advance vaccine manufacturing
    Sara Sousa Rosa, Dale J. Stibbs, Pedro Silva Couto, D.M.F. Prazeres, Ana Margarida Azevedo, Daniel G. Bracewell, Marco P. C. Marques · 2025 · Journal of Chromatography A
  51. Beginning of a new era of synthetic messenger RNA therapeutics: Comprehensive insights on mRNA drug design, development and applications
    Saumya Nishanga Heendeniya, Suxiang Chen, S. H. Bhatti, Qurat ul ain Zahra, Kamal Rahimizadeh, Bal Hari Poudel, Steve Donald Wilton, Rakesh Naduvile Veedu · 2025 · Experimental Biology and Medicine
  52. The 5′ Cap Epitranscriptome and Beyond: Natural and Engineered 5′ Cap Modifications for Optimizing mRNA Therapeutics and Functional Studies
    Greta Charlotte Dahm, Melissa Pieper, Helena Schepers, Andrea Rentmeister · 2026 · ChemMedChem
  53. An engineered linear cap-independent mRNA vaccine with intrinsic adjuvanticity induces potent anti-tumor immunity in mice
    Hongwu Yu, Yu Yang, Peng Lin, Chengye Liu, Yifan Wen, Zihan Huang, Zhuting Fang, Zhixiang Hu, Huang St · 2026 · Nature Communications
  54. Non-viral and mRNA-based strategies for next-generation CAR-T cell therapy
    Taiping Wang, Feng Jin, Wenzheng Xing, Shujuan Yu · 2026 · Pathology - Research and Practice
  55. mRNA medicine for cardiovascular disease
    Zhuoming Zhou, Wei Chen, Haojie Yu, Ira A. Tabas, Roger Foo, Wei Tao · 2026 · Nature Cardiovascular Research
  56. Research progress in mRNA drug modification and delivery systems
    Zhengjie Zhou, Xin Li · 2023 · Journal of Zhejiang University (Medical Sciences)
  57. Research progress on mRNA drug delivery strategies in the nervous system
    Bo Yang, Anqi Liu, Xiaojing Li, Zhigang Miao · 2025 · Nanomedicine
  58. The transcription factor BCL11B drives NK cell cytotoxicity and antitumor activity
    Akhilesh Kumar, Bin Zhang, Andrew M. Baldys, Colin Fischer, Alexander J. Lenvik, Martin Felices, Zachary Davis, Laura E. Bendzick, Anna Weis, Yenan T. Bryceson et al. · 2025 · The Journal of Immunology
  59. Pioneering next-generation mRNA therapeutics through molecular engineering and delivery optimization
    Lin Qi, Zhihong Li, Zunyong Feng, Jianping Liu, Xiaoyuan Shawn Chen · 2025 · Materials Today
  60. mRNA therapy: A novel approach for retinal neurodegenerative diseases
    Bing Zhang, Jiahui Tang, Qiang Zhang, Yuxuan Qiu, Yunjie Cheng, Shilong Yu, Liyan Liu, Jingfei Xue, Xuehan Liu, Quanyu He et al. · 2026 · Neural Regeneration Research
  61. Unlocking the potential of mRNA nanomedicines for comprehensive fibrosis therapy
    Yue Yang, Chaofu Li, Weidong Xiong, Chuanwei Li, Jun Xiao · 2026 · Molecular Therapy — Nucleic Acids
  62. ADVANCES IN THE DEVELOPMENT OF MRNA-VACCINES
    N. S. Golyak, В. М. Царенков, Olga A. Sushinskaya, O. G. Sechko, Мальчёнкова Светлана Степановна · 2025 · Vestnik Farmacii
  63. In vivo immune engineering via mRNA therapeutics: reprogramming the post-infarction cardiac microenvironment
    Y H Liu, Liu R, Chao Meng, Li J, Kai Yang, Fuyuan Zhang, Xiao Xia, Guancheng Ye, Yulian Yuan · 2026 · Frontiers in Immunology
  64. The discovery and development of mRNA vaccines for the prevention of SARS-CoV-2 infection
    Vivian Weiwen Xue, Sze Chuen Cesar Wong, Bo Li, William Chi Shing Cho · 2023 · Expert Opinion on Drug Discovery
  65. Purification of IVT mRNA by 5′ cap affinity chromatography
    Binhe Du, Jinzhong Lin · 2023 · Chinese Science Bulletin (Chinese Version)
  66. The potential of N2-modified cap analogues for precise genetic manipulation through mRNA engineering
    Karol Kurpiejewski, Anna Stankiewicz-Drogoń, Karolina Piecyk, Eliza Rajkowska, Paulina Skrzypczyk, Jingping Geng, Edward Darżynkiewicz, Renata Grzela, Marzena Jankowska‐Anyszka · 2024 · Frontiers in Molecular Biosciences
  67. A Basic Method for Formulating mRNA-Lipid Nanoparticle Vaccines in the Lab
    Natalia Teresa Jarzębska, Julia Frei, Mark Mellett, Thomas M. Kündig, Steve Pascolo, Andreas Michael Reichmuth · 2024 · Methods in molecular biology
  68. Combinative workflow for mRNA vaccine development
    Renuka Khanzode, Garima Soni, Shalini Srivastava, Sharad P. Pawar, Rucha M. Wadapurkar, Ajay Singh · 2024 · Biochemistry and Biophysics Reports
  69. Nanoparticle-Mediated Mucosal Vaccination: Harnessing Nucleic Acids for Immune Enhancement
    Wajid Hussain, Sadia Chaman, Nazia Koser, Syed Muhammad Aun, Zainab Bibi, Ayesha Nasir Pirzadi, Jawad S. Hussain, Zubaria Zubaria, Ghulam Nabi, Muhammad Wajid Ullah et al. · 2024 · Current Microbiology
  70. The rational design of mRNA vaccine: From empirical method to artificial intelligence-based design
    Yuxuan Hu, Chengtao Pu, Boxiang Liu, Liang Zhang · 2024 · Chinese Science Bulletin (Chinese Version)
  71. Application of Mammalian Nudix Enzymes to Capped RNA Analysis
    Maciej Łukaszewicz · 2024 · Pharmaceuticals
  72. A tripartite cell-free translation system to study mammalian translation
    Frederic Schrøder Arendrup, Kasper Langebjerg Andersen, Anders Henrik Lund · 2025 · Nature Protocols
  73. Advancing Protein‐Coding RNA Engineering: From Structural Refinement to Biomedical Implementation
    Xiaohong Lu, Shuangpeng Li, Yue Chi, Shuo Lin, Hui Yuan, Zhiyi Lin, Yingying Xiao, Haihua Yin, Xia Zuo, Ruilin Cheng et al. · 2025 · Biotechnology Journal
  74. Lipid Nanoparticle-Encapsulated TALEN-Encoding mRNA Inactivates Hepatitis B Virus Replication in Cultured Cells and Transgenic Mice
    Tiffany S. Smith, Prashika Singh, Ridhwaanah Bhana, Dylan Kairuz, Kristie M. Bloom, Mohube Betty Maepa, Abdullah Ely, Patrick B. Arbuthnot · 2025 · Viruses
  75. Streamlined DNA template preparation and co-transcriptional 5′ capped RNA synthesis enabled by solid-phase catalysis
    Guillermo García-Marquina, Aihua Zhang, Michael Sproviero, Yi Fang, Andrew F. Gardner, G. Brett Robb, Siu‐Hong Chan, Ming‐Qun Xu · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  76. Co-transcriptional capping using an RNA capping enzyme-T7 RNA polymerase fusion protein
    Siu‐Hong Chan, Louise Tirole, Daniel W. Kneller, Theresa M. Kelley, Nan Dai, G. Brett Robb · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  77. mRNA vaccines for COVID-19
    Anamika Sengupta · 2022 · Elsevier eBooks
  78. Decoding trends in mRNA vaccine research: A comprehensive bibliometric study
    Chaobin Zhang, Yuhang Wang, Jianding Peng, Xiaotian Wen, Youwen Zhang, Kejun Li, Hanjian Du, Xiaofei Hu · 2024 · Human Vaccines & Immunotherapeutics
  79. A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
    Liang Hu, Robert Berahovich, Yanwei Huang, Shiming Zhang, Jinying Sun, Xianghong Liu, Hua Zhou, Shirley Xu, Haoqi Li, Vita Golubovskaya et al. · 2025 · Journal of Visualized Experiments
  80. Optimization of In Vitro Transcription Reaction for mRNA Production Using Chromatographic At-Line Monitoring
    Tjaša Marušič, Tina Vodopivec Seravalli, Anže Martinčič Celjar, Janja Skok, Rok Sekirnik · 2025 · Methods in molecular biology
  81. In-process analytics for IVT mRNA manufacturing: from process understanding to advanced process control
    Naryeong Kim, Emily Dong, Kate Tschudi, Julien Camperi · 2026 · Frontiers in Bioengineering and Biotechnology
  82. CJ-1: an optimized mRNA platform with enhanced protein expression and minimal immunogenicity for therapeutic applications
    Seyoung Kim, Min Ju Jo, Min Seon Jeong, Minki Ha, Youngwook Ham, Jiye Hong, Daeyong Kim, Kyuha Yum, Jaewook Yeon, Sang‐Bae Han et al. · 2026 · Gene Therapy
  83. Decoding Self vs. Non-Self: Alphavirus Cap0 Recognition and Immune Evasion
    Santiago Enrique Faraj, Claudia V. Filomatori · 2026 · Viruses
  84. Cross-protective efficacy of NA-based mRNA vaccine candidates against seasonal and avian influenza viruses
    Hyunbeen Kim, Sangyi Lee, Seunghye Cho, Woojin Shin, Soyoung Lee, S M Park, Atanas Vladimirov Demirev, Taeyoung Lee, You-Jin Kim, Dokeun Kim et al. · 2026 · Frontiers in Microbiology
  85. A Modular Mechanistic In Silico Model for In Vitro Transcription Process Yield and Product Quality Prediction
    Keqi Wang, Keilung Choy, Eli Reiser, Jinxiang Pei, Hua Zheng, Aparajita Dasgupta, Fuqiang Cheng, Guogang Dong, Bhanu Chandra Mulukutla, Joshua Mannheimer et al. · 2026 · Biotechnology and Bioengineering
  86. https://onco-hema.healthbooktimes.org/article/29047-mrna-vaccines-against-infectious-diseases-and-cancer?auth_token=GXnDwFXw-1WxSg9ozO7O
    Alexander Meisel, Steve Pascolo · 2021 · healthbook TIMES Oncology Hematology
  87. Ribonucleases for Sequencing and Characterization of RNA by LC–MS
    Ivan Reis Correa Junior, Eric J. Wolf, Erbay Yigit, Siu‐Hong Chan · 2023 · RNA technologies
  88. The science of mRNA
    Anya M Hillery · 2024 · Elsevier eBooks
  89. The Eukaryotic mRNA Cap Structure
    Jerry Pelletier, Nahum Sonenberg · 2023 · Encyclopedia of Life Sciences
  90. mRNA Therapeutics and mRNA Vaccines
    Keiji Itaka · 2021 · TRENDS IN THE SCIENCES
  91. Expanding the analytical toolbox for synthesis and characterization of ribonucleic acids
    Steven R. Strezsak · 2022
  92. Synthetic mRNA Gene Therapies and Hepatotropic Non-viral Vectors for the Treatment of Chronic HBV Infections
    Dylan Kairuz, Prashika Singh, Tiffany S. Smith, Patrick B. Arbuthnot, Abdullah Ely, Kristie M. Bloom · 2022 · RNA technologies
  93. A Possible Blue Print of Addressing mRNA Vaccine Efficacy
    Boran Li · 2023 · Highlights in Science Engineering and Technology
  94. Design and Generation of MRNAS Encoding Conserved Regions of SARS-Cov-2 ORf1Ab for T Cell-Mediated Immune Activation
    Cao Minh Nguyen, Bac An Luong, Thu Thuy Tran, Hoai‐Nghia Nguyen, Le Son Tran · 2023 · Future Virology
  95. Trinucleotide mRNA cap analog N6-benzylated at the site of posttranscriptional m6 Am mark facilitates mRNA purification and confers superior translational properties in vitro and in vivo
    Marcin Warmiński, Edyta Trepkowska, Mirosław Śmietański, Pawel J. Sikorski, Marek R. Baranowski, Marcelina Bednarczyk, Hanna Kędzierska, Bartosz Majewski, Adam Mamot, Diana Papiernik et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  96. Isolation of Double-Stranded RNAs by Lithium Chloride Fractionation
    Mengzhu Chai, Xinyue Ma, Shuaifa Chang, Xiaofei Cheng · 2024 · Methods in molecular biology
  97. The P(III)‐Amidite Based Synthesis of Stable Isotope Labeled mRNA‐Cap‐Structures Enables their Sensitive Quantitation from Brain Tissue
    Alexander Ripp, Martina Krämer, Vanessa Barth, Patrick Moser, Thomas Haas, Jyoti Singh, Tamara Huck, Lukas Gleue, Kristina Friedland, Mark Helm et al. · 2024 · Angewandte Chemie
  98. Purification of Enzymatically Active Xrn1 for Removal of Non-capped mRNAs from In Vitro Transcription Reactions and Evaluation of mRNA Decapping Status In Vivo
    Karolina Drążkowska, Rafał Tomecki, Agnieszka Tudek · 2024 · Methods in molecular biology
  99. COVID-19 Vaccine Manufacturing Processes: Making the Molecules to Solve the Pandemic
    Jennifer A. S. Romine, Stephen A. Kolodziej, Tarl Vetter, Michael P. Dux · 2024 · Springer eBooks
  100. Advances in the development of therapeutic mRNA vaccines for cancer therapy
    Kexin Deng, Xiaobin Li, Wanwan Liu, Junyu Liu, Runming Wang, Yandong Yin, Can Yang Zhang · 2024 · Chinese Science Bulletin (Chinese Version)